NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Copyright Public domain Remove constraint Copyright: Public domain Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months Recently Added Within 3 Months Remove constraint Recently Added: Within 3 Months Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

1. Advancing primary prevention in human services. Opportunities for people with lived experience

2. Advancing primary prevention in human services. Key considerations for policy designers and funding partners

3. Advancing primary prevention in human services. Key considerations for administrators and practitioners

4. Medicare Part B drugs: trends in spending and utilization, 2008-2021

5. Medicare Part D enrollee out-of-pocket spending: recent trends and projected impacts of the Inflation Reduction Act

6. Updated Medicare FFS telehealth trends by beneficiary characteristics, visit specialty, and state, 2019-2021

12. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

15. During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections

20. Inaccuracies in Medicare’s race and ethnicity data hinder the ability to assess health disparities

27. FDA’s approach to overseeing online tobacco retailers needs improvement

34. COVID-19 mortality rates across noncore, micropolitan, and metropolitan counties by community characteristics, December 2020-January 2021

35. State-based recommendations to support rural ambulance agencies

37. The role of telehealth in achieving a high performing rural health system: priorities in a post-pandemic system

46. More than a thousand nursing homes reached infection rates of 75 percent or more in the first year of the COVID-19 pandemic: better protections are needed for future emergencies

48. High rates of prior authorization denials by some plans and limited state oversight raise concerns about access to care in Medicaid managed care

53. Home health agencies failed to report over half of falls with major injury and hospitalization among their Medicare patients

57. In five states, there was no evidence that many children in foster care had a screening for sex trafficking when they returned after going missing

58. Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic

60. For Medicaid-enrolled children diagnosed with lead toxicity in five states, documentation reviewed for diagnoses and treatment services raises concerns

61. Meeting the behavioral health needs of farm families in times of economic distress

62. Nursing homes in rural America: a chartbook : key facts about nursing home availability in rural America

63. Health insurance marketplaces: issuer participation trends in non-metropolitan places, 2014-22

64. An insurance profile of rural America: chartbook : key facts about insurance coverage and healthcare access in rural America

65. The evolution of hospital designations and payment in the U.S: implications for rural hospitals

73. Institutional review board (IRB) review of individual patient expanded access submissions for investigational drugs and biological products: guidance for IRBs and clinical investigators

74. Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process": guidance for industry and Food and Drug Administration staff

79. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

80. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies : guidance for industry

82. Voluntary consensus standards recognition program for regenerative medicine therapies: guidance for industry

86. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry

88. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry

96. Income of working-age veterans receiving disability compensation

97. Exploring the effects of Medicaid during childhood on the economy and the budget

99. Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate

100. Federal subsidies for health insurance: 2023 to 2033